Literature DB >> 190606

Properties of sterol biosynthesis in human leukocytes: effects of gemfibrozil.

D J Betteridge, M J Higgins, D J Galton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 190606      PMCID: PMC1864012     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  6 in total

1.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity in type II hyperlipoproteinaemia.

Authors:  D J Betteridge; M J Higgins; D J Galton
Journal:  Br Med J       Date:  1975-11-29

2.  Errors in metabolic regulation. A common group of metabolic disorders.

Authors:  D J Galton; M J Higgins; J P Reckless
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

3.  A new type of familial hypercholesterolaemia.

Authors:  M J Higgins; D S Lecamwasam; D J Galton
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

4.  Abnormal induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia.

Authors:  A M Fogelman; J Edmond; J Seager; G Popják
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

5.  Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.

Authors:  J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

6.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

  6 in total
  2 in total

Review 1.  Gemfibrozil, stretching arms beyond lipid lowering.

Authors:  Avik Roy; Kalipada Pahan
Journal:  Immunopharmacol Immunotoxicol       Date:  2009       Impact factor: 2.730

2.  Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers.

Authors:  Marie N S Gendy; Patricia Di Ciano; William J Kowalczyk; Sean P Barrett; Tony P George; Stephen Heishman; Bernard Le Foll
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.